RHÖN-KLINIKUM Aktiengesellschaft (RKAGY)
USD 6.05
(0.0%)
USD 6.05
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 136.24 Million EUR | -86.37% |
| 2022 | 999.52 Million EUR | 2.87% |
| 2021 | 971.61 Million EUR | 3.61% |
| 2020 | 937.72 Million EUR | 4.66% |
| 2019 | 895.97 Million EUR | 4.13% |
| 2018 | 860.46 Million EUR | -0.35% |
| 2017 | 863.52 Million EUR | 1.97% |
| 2016 | 846.8 Million EUR | 7.69% |
| 2015 | 786.35 Million EUR | -27.55% |
| 2014 | 1.08 Billion EUR | -51.16% |
| 2013 | 2.22 Billion EUR | 5.24% |
| 2012 | 2.11 Billion EUR | 8.26% |
| 2011 | 1.95 Billion EUR | 3.01% |
| 2010 | 1.89 Billion EUR | 9.77% |
| 2009 | 1.72 Billion EUR | 8.46% |
| 2008 | 1.59 Billion EUR | -36.92% |
| 2007 | 2.52 Billion EUR | 3.97% |
| 2006 | 2.42 Billion EUR | 37.83% |
| 2005 | 1.75 Billion EUR | 35.63% |
| 2004 | 1.29 Billion EUR | 78.71% |
| 2003 | 725.84 Million EUR | 8.69% |
| 2002 | 667.8 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -14.29 Million EUR | 348.29% |
| 2024 Q1 | -21.12 Million EUR | 0.32% |
| 2023 Q4 | -21.19 Million EUR | -108.84% |
| 2023 Q3 | 239.76 Million EUR | -3.91% |
| 2023 Q2 | 249.52 Million EUR | 3.3% |
| 2023 FY | 136.24 Million EUR | -86.37% |
| 2023 Q1 | 241.56 Million EUR | -7.01% |
| 2022 Q2 | 257.42 Million EUR | 7.35% |
| 2022 Q4 | 259.76 Million EUR | 7.1% |
| 2022 Q3 | 242.54 Million EUR | -5.78% |
| 2022 Q1 | 239.79 Million EUR | -7.13% |
| 2022 FY | 999.52 Million EUR | 2.87% |
| 2021 FY | 971.61 Million EUR | 3.61% |
| 2021 Q4 | 258.2 Million EUR | 8.79% |
| 2021 Q1 | 233.47 Million EUR | -1.06% |
| 2021 Q3 | 237.34 Million EUR | -2.16% |
| 2021 Q2 | 242.59 Million EUR | 3.91% |
| 2020 Q2 | 236.87 Million EUR | 4.29% |
| 2020 Q4 | 235.97 Million EUR | -0.75% |
| 2020 FY | 937.72 Million EUR | 4.66% |
| 2020 Q1 | 227.12 Million EUR | 0.81% |
| 2020 Q3 | 237.75 Million EUR | 0.37% |
| 2019 Q2 | 220.09 Million EUR | -3.54% |
| 2019 Q4 | 225.3 Million EUR | 1.31% |
| 2019 FY | 895.97 Million EUR | 4.13% |
| 2019 Q1 | 228.18 Million EUR | 8.13% |
| 2019 Q3 | 222.38 Million EUR | 1.04% |
| 2018 Q2 | 217.56 Million EUR | -0.58% |
| 2018 Q3 | 213.04 Million EUR | -2.08% |
| 2018 FY | 860.46 Million EUR | -0.35% |
| 2018 Q1 | 218.83 Million EUR | 0.93% |
| 2018 Q4 | 211.02 Million EUR | -0.95% |
| 2017 FY | 863.52 Million EUR | 1.97% |
| 2017 Q2 | 212.52 Million EUR | -1.94% |
| 2017 Q3 | 217.44 Million EUR | 2.31% |
| 2017 Q1 | 216.73 Million EUR | 2.56% |
| 2017 Q4 | 216.82 Million EUR | -0.29% |
| 2016 Q2 | 214.22 Million EUR | 1.59% |
| 2016 FY | 846.8 Million EUR | 7.69% |
| 2016 Q1 | 210.87 Million EUR | 9.16% |
| 2016 Q4 | 211.32 Million EUR | 0.45% |
| 2016 Q3 | 210.37 Million EUR | -1.79% |
| 2015 Q3 | 195.73 Million EUR | -2.75% |
| 2015 Q4 | 193.18 Million EUR | -1.3% |
| 2015 Q1 | 196.17 Million EUR | 3.66% |
| 2015 Q2 | 201.26 Million EUR | 2.6% |
| 2015 FY | 786.35 Million EUR | -27.55% |
| 2014 FY | 1.08 Billion EUR | -51.16% |
| 2014 Q4 | 189.23 Million EUR | -4.54% |
| 2014 Q3 | 198.23 Million EUR | -15.49% |
| 2014 Q2 | 234.56 Million EUR | -49.38% |
| 2014 Q1 | 463.37 Million EUR | -16.69% |
| 2013 Q2 | 557.27 Million EUR | 0.06% |
| 2013 Q3 | 551.78 Million EUR | -0.99% |
| 2013 FY | 2.22 Billion EUR | 5.24% |
| 2013 Q4 | 556.18 Million EUR | 0.8% |
| 2013 Q1 | 556.92 Million EUR | 1.55% |
| 2012 Q1 | 504.27 Million EUR | 1.78% |
| 2012 Q2 | 521.58 Million EUR | 3.43% |
| 2012 Q3 | 537.26 Million EUR | 3.01% |
| 2012 Q4 | 548.43 Million EUR | 2.08% |
| 2012 FY | 2.11 Billion EUR | 8.26% |
| 2011 Q2 | 485.55 Million EUR | 1.25% |
| 2011 Q4 | 495.45 Million EUR | 1.13% |
| 2011 FY | 1.95 Billion EUR | 3.01% |
| 2011 Q1 | 479.58 Million EUR | 0.85% |
| 2011 Q3 | 489.92 Million EUR | 0.9% |
| 2010 Q1 | 463.04 Million EUR | 5.3% |
| 2010 Q3 | 477.2 Million EUR | -0.1% |
| 2010 Q4 | 475.54 Million EUR | -0.35% |
| 2010 Q2 | 477.69 Million EUR | 3.16% |
| 2010 FY | 1.89 Billion EUR | 9.77% |
| 2009 Q3 | 434.03 Million EUR | -0.35% |
| 2009 FY | 1.72 Billion EUR | 8.46% |
| 2009 Q4 | 439.75 Million EUR | 1.32% |
| 2009 Q2 | 435.56 Million EUR | 4.82% |
| 2009 Q1 | 415.53 Million EUR | 0.0% |
| 2008 FY | 1.59 Billion EUR | -36.92% |
| 2007 FY | 2.52 Billion EUR | 3.97% |
| 2006 FY | 2.42 Billion EUR | 37.83% |
| 2005 FY | 1.75 Billion EUR | 35.63% |
| 2004 FY | 1.29 Billion EUR | 78.71% |
| 2003 FY | 725.84 Million EUR | 8.69% |
| 2002 FY | 667.8 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| The Amacore Group, Inc. | 9.39 Million USD | -1349.771% |
| Arem Pacific Corporation | 239.16 Thousand USD | -56867.244% |
| Assisted 4 Living, Inc. | 712.32 Thousand USD | -19026.69% |
| BioCorRx Inc. | 53.17 Thousand USD | -256122.966% |
| Bionik Laboratories Corp. | 989.87 Thousand USD | -13663.73% |
| Banyan Corp. | 5 Million USD | -2622.871% |
| Clearday, Inc. | -6.84 Million USD | 2089.081% |
| Dental Patient Care America, Inc. | 3.24 Million USD | -4099.484% |
| Quantum Medical Transport, Inc. | 1097.61 USD | -12412687.784% |
| Empower Clinics Inc. | 1.96 Million USD | -6822.887% |
| First Choice Healthcare Solutions, Inc. | -12.19 Thousand USD | 1117220.367% |
| Selectis Health, Inc. | 5.4 Million USD | -2419.712% |
| Ethema Health Corporation | 4.66 Million USD | -2818.157% |
| HealthLynked Corp. | 2.34 Million USD | -5700.675% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 6.78 Million USD | -1908.138% |
| JRSIS Health Care Corporation | 483.05 Thousand USD | -28104.889% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 143.69 Million USD | 5.187% |
| MedSmart Group Inc. | -19.03 Thousand USD | 715742.399% |
| North America Frac Sand, Inc. | 73.25 Thousand USD | -185883.401% |
| Nova Leap Health Corp. | 9.76 Million USD | -1294.745% |
| Nexteligent Holdings, Inc. | 351.66 Thousand USD | -38642.774% |
| PAO Group, Inc. | - USD | -Infinity% |
| Primemd Inc. | 10.5 Million USD | -1197.354% |
| Raffles Medical Group Ltd | 239.4 Million USD | 43.091% |
| Ryman Healthcare Limited | 260.65 Million USD | 47.73% |
| Stem Cell Authority, Ltd. | - USD | -Infinity% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | -1.21 Million USD | 11348.113% |
| Mycotopia Therapies, Inc. | -61.21 Thousand USD | 222659.093% |
| U.S. NeuroSurgical Holdings, Inc. | -20 Thousand USD | 681320.0% |
| Veltex Corporation | 694.58 Thousand USD | -19515.138% |
| World Financial Holding Group | - USD | -Infinity% |
| Xcelerate Inc. | 294.11 Thousand USD | -46223.062% |